|
1
|
Yue HY, Yin C, Hou JL, Zeng X, Chen YX,
Zhong W, Hu PF, Deng X, Tan YX, Zhang JP, et al: Hepatocyte nuclear
factor 4alpha attenuates hepatic fibrosis in rats. Gut. 59:236–246.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xue ZF, Wu XM and Liu M: Hepatic
regeneration and the epithelial to mesenchymal transition. World J
Gastroenterol. 19:1380–1386. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Neuparth MJ, Proença JB, Santos-Silva A
and Coimbra S: Adipokines, oxidized low-density lipoprotein, and
C-reactive protein levels in lean, overweight, and obese portuguese
patients with type 2 diabetes. ISRN Obes.
2013:1420972013.PubMed/NCBI
|
|
4
|
Karadeniz G, Acikgoz S, Tekin IO, Tascýlar
O, Gun BD and Cömert M: Oxidized low-density-lipoprotein
accumulation is associated with liver fibrosis in experimental
cholestasis. Clinics (Sao Paulo). 63:531–540. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li J, Fan R, Zhao S, Liu L, Guo S, Wu N,
Zhang W and Chen P: Reactive oxygen species released from hypoxic
hepatocytes regulates MMP-2 expression in hepatic stellate cells.
Int J Mol Sci. 12:2434–2447. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bai YP, Hu CP, Chen MF, Xu KP, Tan GS, Shi
RZ, Li YJ and Zhang GG: Inhibitory effect of reinioside C on
monocyte-endothelial cell adhesion induced by oxidized low-density
lipoprotein via inhibiting NADPH oxidase/ROS/NF-kappaB pathway.
Naunyn Schmiedebergs Arch Pharmacol. 380:399–406. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kose E, An T, Kikkawa A, Matsumoto Y and
Hayashi H: Effects on serum uric acid by difference of the renal
protective effects with atorvastatin and rosuvastatin in chronic
kidney disease patients. Biol Pharm Bull. 37:226–231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Y, Wang Q, Zhou J, Xu Q, Chu X, Sun T,
Liu X and Cai S: Rosuvastatin attenuates atherosclerosis in rats
via activation of scavenger receptor class B type I. Eur J
Pharmacol. 723:23–28. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ansari JA, Bhandari U, Haque SE and Pillai
KK: Enhancement of antioxidant defense mechanism by pitavastatin
and rosuvastatin on obesity-induced oxidative stress in Wistar
rats. Toxicol Mech Methods. 22:67–73. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aktas C, Kanter M, Erboga M, Mete R and
Oran M: Melatonin attenuates oxidative stress, liver damage and
hepatocyte apoptosis after bile-duct ligation in rats. Toxicol Ind
Health. 30:835–844. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ezhilarasan D, Karthikeyan S and
Vivekanandan P: Ameliorative effect of silibinin against
N-nitrosodimethylamine-induced hepatic fibrosis in rats. Environ
Toxicol Pharmacol. 34:1004–1013. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hong HK, Song CY, Kim BC and Lee HS: ERK
contributes to the effects of Smad signaling on oxidized
LDL-induced PAI-1 expression in human mesangial cells. Transl Res.
148:171–179. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee HS and Song CY: Oxidized low-density
lipoprotein and oxidative stress in the development of
glomerulosclerosis. Am J Nephrol. 29:62–70. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Turer AT and Scherer PE: Adiponectin:
Mechanistic insights and clinical implications. Diabetologia.
55:2319–2326. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen Z, Li S, Zhao W, Chen X and Wang X:
Protective effect of co-administration of rosuvastatin and probucol
on atherosclerosis in rats. Can J Physiol Pharmacol. 92:797–803.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hulthe J and Fagerberg B: Circulating
oxidized LDL is associated with subclinical atherosclerosis
development and inflammatory cytokines (AIR Study). Arterioscler
Thromb Vasc Biol. 22:1162–1167. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fan X, Wang J, Hou J, Lin C, Bensoussan A,
Chang D, Liu J and Wang B: Berberine alleviates ox-LDL induced
inflammatory factors by up-regulation of autophagy via AMPK/mTOR
signaling pathway. J Transl Med. 13:922015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yao S, Zong C, Zhang Y, Sang H, Yang M,
Jiao P, Fang Y, Yang N, Song G and Qin S: Activating transcription
factor 6 mediates oxidized LDL-induced cholesterol accumulation and
apoptosis in macrophages by up-regulating CHOP expression. J
Atheroscler Thromb. 20:94–107. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiong G, Li L, Sun S, Li T, Liao D, Shu C
and Tuo Q: Subcellular localization of DAXX influence ox-LDL
induced apoptosis in macrophages. Mol Biol Rep. 41:7183–7190. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Samarakoon R, Overstreet JM and Higgins
PJ: TGF-β signaling in tissue fibrosis: Redox controls, target
genes and therapeutic opportunities. Cell Signal. 25:264–268. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Samarakoon R, Overstreet JM, Higgins SP
and Higgins PJ: TGF-β1→SMAD/p53/USF2→PAI-1 transcriptional axis in
ureteral obstruction-induced renal fibrosis. Cell Tissue Res.
347:117–128. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Antus B, Harnasi G, Drozdovszky O and
Barta I: Monitoring oxidative stress during chronic obstructive
pulmonary disease exacerbations using malondialdehyde. Respirology.
19:74–79. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Youseff BH, Holbrook ED, Smolnycki KA and
Rappleye CA: Extracellular superoxide dismutase protects
Histoplasma yeast cells from host-derived oxidative stress. PLoS
Pathog. 8:e10027132012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Resch U, Tatzber F, Budinsky A and
Sinzinger H: Reduction of oxidative stress and modulation of
autoantibodies against modified low-density lipoprotein after
rosuvastatin therapy. Br J Clin Pharmacol. 61:262–274. 2006.
View Article : Google Scholar : PubMed/NCBI
|
